BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

PharmaCyte Biotech (Formerly Known As Nuvilex) 

1971 Old Cuthbert Road

Cherry Hill  New Jersey  08034  U.S.A.
Phone: 856-433-6088 Fax: 856-354-1077


SEARCH JOBS




Industry
Biotechnology






 Company News
PharmaCyte Biotech (NVLX)'s Scientific Advisory Board Chairman Publishes Review Article On The Pathology Of Pancreatic Cancer 2/24/2015 10:40:31 AM
Nuvilex Announces Name Change To PharmaCyte Biotech (NVLX) 1/7/2015 10:02:57 AM
Nuvilex (NVLX) To Attend 2015 Gastrointestinal Cancers Symposium In San Francisco, January 15-17, 2015 1/6/2015 10:06:22 AM
FDA Grants Orphan Drug Designation To Nuvilex (NVLX) For Pancreatic Cancer Treatment 12/22/2014 7:25:23 AM
Nuvilex (NVLX)'s Partner Austrianova Successfully Completes First Live Cell Encapsulation In New Facility 12/18/2014 8:08:46 AM
Nuvilex (NVLX) Provides Shareholder Update On Cancer And Diabetes Programs 12/16/2014 7:58:24 AM
Nuvilex (NVLX) Provides Update On Significance Of Austrianova's cGMP Live-Cell Encapsulation Facility 12/11/2014 7:31:37 AM
Nuvilex (NVLX) Announces Name Change Of Subsidiary To Viridis Biotech 12/8/2014 8:44:17 AM
Nuvilex (NVLX) Obtains Exclusive Worldwide License To Develop Disease Treatments That Combine Cell-In-A-Box(R) And Cannabinoid-Based Medicine 12/2/2014 11:44:41 AM
Nuvilex (NVLX) Announces The Formation Of A Diabetes Consortium For The Development Of Its Treatment For Insulin-Dependent Diabetes 11/24/2014 2:59:33 PM
12345678910...